Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving ...

A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal ...

A man who took part in a groundbreaking trial for a new bowel cancer treatment regime has described how his cancer “melted away”. Christopher Burston, 73, was one of 32 patients recruited for a study ...

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of ...

Researchers report encouraging long-term results from an experimental treatment approach that rethinks the timing of cancer ...

A da Vinci SP system was used for two successful surgeries at ECU Health. The technology is less invasive and used one single ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...

Small intestine cancer is rare, with adenocarcinomas being the most common type, often occurring in the duodenum. Diagnosis involves imaging, endoscopy, and biopsy, with staging determined by the TNM ...